Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 3610-3614, July 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobayashi, H.
Right arrow Articles by Terao, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, H.
Right arrow Articles by Terao, T.

Inhibition of in Vitro Ovarian Cancer Cell Invasion by Modulation of Urokinase-type Plasminogen Activator and Cathepsin B

Hiroshi Kobayashi1, Hidekazu Ohi, Motoi Sugimura, Hiromitsu Shinohara, Toshiro Fujii and Toshihiko Terao

Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Handacho 3600, Hamamatsu, Shizuoka, 431-31, Japan

HOC-I ovarian cancer cells express the single-chain form of the urokinase-type plasminogen activator (uPA) and cathepsin B (cath B) on their cell surface. The significance of the expression of cell surface uPA/cath B activity to the invasive potential was examined by preincubating with uPA/cath B-modulating agents in in vitro invasion assay. The anti-uPA monoclonal antibody 394 effectively inhibited invasion in a dose-dependent manner. On the contrary, anti-cath B antibody did not affect the invasive potential of the cells. E-64, a specific inhibitor for cysteine proteases, blocked invasion as effectively as monoclonal antibody 394. The data reveal that the uPA and cysteine proteases contribute significantly to the invasive capacity of the cells. We suggest that the cysteine proteases facilitate the action of uPA, possibly by activating proenzyme uPA produced by cancer cells. Evidence for the role of a cathepsin-uPA activation cascade in HOC-I cell invasion is provided.

1 To whom requests for reprints should be addressed.

Received 2/ 7/92. Accepted 4/24/92.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
E. M. Kovacs, R. S. Makar, and F. B. Gertler
Tuba stimulates intracellular N-WASP-dependent actin assembly
J. Cell Sci., July 1, 2006; 119(13): 2715 - 2726.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
L. C. Huber, O. Distler, I. Tarner, R. E. Gay, S. Gay, and T. Pap
Synovial fibroblasts: key players in rheumatoid arthritis
Rheumatology, June 1, 2006; 45(6): 669 - 675.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. W.M. van Hinsbergh, M. A. Engelse, and P. H.A. Quax
Pericellular Proteases in Angiogenesis and Vasculogenesis
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 716 - 728.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. E. Graves, E. V. Ariztia, J. R. Navari, H. J. Matzel, M. S. Stack, and D. A. Fishman
Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles
Cancer Res., October 1, 2004; 64(19): 7045 - 7049.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Huber, D. Vlasny, S. Jeckel, F. Stubenrauch, and T. Iftner
Gene Profiling of Cottontail Rabbit Papillomavirus-Induced Carcinomas Identifies Upregulated Genes Directly Involved in Stroma Invasion as Shown by Small Interfering RNA-Mediated Gene Silencing
J. Virol., July 15, 2004; 78(14): 7478 - 7489.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. S. Gondi, S. S. Lakka, N. Yanamandra, W. C. Olivero, D. H. Dinh, M. Gujrati, C. H. Tung, R. Weissleder, and J. S. Rao
Adenovirus-Mediated Expression of Antisense Urokinase Plasminogen Activator Receptor and Antisense Cathepsin B Inhibits Tumor Growth, Invasion, and Angiogenesis in Gliomas
Cancer Res., June 15, 2004; 64(12): 4069 - 4077.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
P. A. Reynolds, G. A. Smolen, R. E. Palmer, D. Sgroi, V. Yajnik, W. L. Gerald, and D. A. Haber
Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein
Genes & Dev., September 1, 2003; 17(17): 2094 - 2107.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. C. McDonnel, E. A. Van Kirk, D. D. Isaak, and W. J. Murdoch
Inhibitory Effects of Progesterone on Plasma Membrane Fluidity and Tumorigenic Potential of Ovarian Epithelial Cancer Cells
Experimental Biology and Medicine, March 1, 2003; 228(3): 308 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Vakili, L. Standker, M. Detheux, G. Vassart, W.-G. Forssmann, and M. Parmentier
Urokinase Plasminogen Activator and Plasmin Efficiently Convert Hemofiltrate CC Chemokine 1 into Its Active [9-74] Processed Variant
J. Immunol., September 15, 2001; 167(6): 3406 - 3413.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Szpaderska and A. Frankfater
An Intracellular Form of Cathepsin B Contributes to Invasiveness in Cancer
Cancer Res., April 1, 2001; 61(8): 3493 - 3500.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
L. G. M. Hazen, F. E. Bleeker, B. Lauritzen, S. Bahns, J. Song, A. Jonker, B. E. M. Van Driel, H. Lyon, U. Hansen, A. Köhler, et al.
Comparative Localization of Cathepsin B Protein and Activity in Colorectal Cancer
J. Histochem. Cytochem., October 1, 2000; 48(10): 1421 - 1430.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
M.-H. Wang, A. L. Kurtz, and Y.-Q. Chen
Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells
Carcinogenesis, August 1, 2000; 21(8): 1507 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Krueger, C. Haeckel, F. Buehling, and A. Roessner
Inhibitory Effects of Antisense Cathepsin B cDNA Transfection on Invasion and Motility in a Human Osteosarcoma Cell Line
Cancer Res., December 1, 1999; 59(23): 6010 - 6014.
[Abstract] [Full Text] [PDF]


Home page
Journal of Bioactive and Compatible PolymersHome page
J. Pato, K. Ulbrich, V. Subr, P. Baker, G. Mezo, and F. Hudecz
Synthesis of Macromolecular Conjugates of a Urokinase Inhibitor: Amiloride
Journal of Bioactive and Compatible Polymers, March 1, 1999; 14(2): 99 - 121.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Takahashi, Z. Sheng, T. P. Horan, H. Kitayama, M. Maki, K. Hitomi, Y. Kitaura, S. Takai, R. M. Sasahara, A. Horimoto, et al.
Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK
PNAS, October 27, 1998; 95(22): 13221 - 13226.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Tsujii, S. Kawano, and R. N. DuBois
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
PNAS, April 1, 1997; 94(7): 3336 - 3340.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M.F. Khan and D. J. Falcone
Role of Laminin in Matrix Induction of Macrophage Urokinase-type Plasminogen Activator and 92-kDa Metalloproteinase Expression
J. Biol. Chem., March 28, 1997; 272(13): 8270 - 8275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Yebra, G. C.N. Parry, S. Stromblad, N. Mackman, S. Rosenberg, B. M. Mueller, and D. A. Cheresh
Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin alpha vbeta 5-directed Cell Migration
J. Biol. Chem., November 15, 1996; 271(46): 29393 - 29399.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.